A methodological assessment of randomization integrity in alteplase for acute ischemic stroke individual patient data meta-analyses
dc.contributor.author | Mickenautsch, Steffen | |
dc.contributor.author | Garg, Ravi | |
dc.contributor.author | Torrealba-Acosta, Gabriel | |
dc.date.accessioned | 2025-07-25T09:33:36Z | |
dc.date.available | 2025-07-25T09:33:36Z | |
dc.date.issued | 2025 | |
dc.description.abstract | Objectives Little is known about the integrity of randomization for randomized controlled trials (RCT) included in alteplase for stroke meta-analyses. If the RCTs were not properly randomized, the results could not be accepted at face value. The objective was to assess the integrity of randomization in individual patient data (IPD) meta-analyses supporting alteplase for acute ischemic stroke. Methods We assessed randomization reporting, performed qualitative risk of bias assessments arising from the randomization process, and performed fixed effects meta-analyses of baseline variables for which zero heterogeneity is expected if all included RCTs have unbiased randomization. Fixed-effects meta-analyses of baseline age, weight, and National Institute of Health Stroke Scale (NIHSS) score were performed. If heterogeneity was present (I2 > 0%), trials were systematically removed, starting with the RCT with the largest t-statistic until the I2 value was 0%. Results The NINDS rt-PA Stroke Study had a high risk of bias, the ECASS-3 RCT had some concerns, and all other trials were graded as low risk according to the Cochrane Risk of Bias (ROB-2) tool. The NINDS rt-PA Stroke Study contributed to heterogeneity in age and weight meta-analyses, and the ECASS-3 RCT contributed to heterogeneity in the NIHSS score meta-analysis. Removal of suspect trials resulted in the expected I2 value of 0%. Conclusions: The NINDS rt-PA Stroke Study and ECASS-3 trials contributed to heterogeneity in fixed effects meta-analyses of baseline variables while there should have been none. These RCTs are likely a source of selection bias in IPD meta-analyses due to suspect randomization. | |
dc.identifier.citation | Garg, R., Torrealba-Acosta, G., Mickenautsch, S. and Berger, V.W., 2025. A methodological assessment of randomization integrity in alteplase for acute ischemic stroke individual patient data meta-analyses. PloS one, 20(3), p.e0315342. | |
dc.identifier.uri | https://doi.org/10.1371/journal.pone.0315342 | |
dc.identifier.uri | https://hdl.handle.net/10566/20613 | |
dc.language.iso | en | |
dc.publisher | Public Library of Science | |
dc.subject | ECASS-3 RCT | |
dc.subject | Objectives | |
dc.subject | RCTs | |
dc.subject | National Institute of Health Stroke Scale (NIHSS) | |
dc.subject | Fixed-effects | |
dc.title | A methodological assessment of randomization integrity in alteplase for acute ischemic stroke individual patient data meta-analyses | |
dc.type | Article |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- mickenautsch_a_methodological _assessment _of _randomization_2025.pdf
- Size:
- 636.59 KB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: